Role of HbA1c in the Screening of Diabetes Mellitus in a Korean Rural Community

被引:11
作者
Kim, Jae Hyun [1 ]
Kim, Gun Woo [1 ]
Lee, Mi Young [1 ]
Shin, Jang Yel [1 ]
Shin, Young Goo [1 ]
Koh, Sang Baek [2 ]
Chung, Choon Hee [1 ,3 ]
机构
[1] Yonsei Univ, Wonju Coll Med, Dept Internal Med, 162 Ilsan Dong, Wonju 220701, South Korea
[2] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea
[3] Yonsei Univ, Wonju Coll Med, Inst Lifestyle Med, Wonju, South Korea
关键词
Diabetes mellitus; Diagnosis; Hemoglobin A; glycosylated; Screening;
D O I
10.4093/dmj.2012.36.1.37
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recently, the measurement of glycated hemoglobin (HbA1c) was recommended as an alternative to fasting plasma glucose or oral glucose tolerance tests for diagnosing diabetes mellitus (DM). In this study, we analyzed HbA1c levels for diabetes mellitus screening in a Korean rural population. Methods: We analyzed data from 10,111 subjects from a Korean Rural Genomic Cohort study and generated a receiver operating characteristic curve to determine an appropriate HbA1c cutoff value for diabetes. Results: The mean age of the subjects was 56.3 +/- 8.1 years. Fasting plasma glucose and 2-hour plasma glucose after 75 g oral glucose tolerance tests were 97.5 +/- 25.6 and 138.3 +/- 67.1 mg/dL, respectively. The mean HbA1c level of the subjects was 5.7 +/- 0.9%. There were 8,809 non-DM patients (87.1%) and 1,302 DM patients (12.9%). A positive relationship between HbA1c and plasma glucose levels and between HbA1c and 2-hour plasma glucose levels after oral glucose tolerance tests was found in a scatter plot of the data. Using Youden's index, the proper cutoff level of HbA1c for diabetes mellitus screening was 5.95% (sensitivity, 77%; specificity, 89.4%). Conclusion: Our results suggest that the optimal HbA1c level for DM screening is 5.95%.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 32 条
[21]   Use of GHb (HbA1c) in screening for undiagnosed diabetes in che US population [J].
Rohlfing, CL ;
Little, RR ;
Wiedmeyer, HM ;
England, JD ;
Madsen, R ;
Harris, MI ;
Flegal, KM ;
Eberhardt, MS ;
Goldstein, DE .
DIABETES CARE, 2000, 23 (02) :187-191
[22]  
Sacks DB, 2002, CLIN CHEM, V48, P436
[23]   A new look at screening and diagnosing diabetes mellitus [J].
Saudek, Christopher D. ;
Herman, William H. ;
Sacks, David B. ;
Bergenstal, Richard M. ;
Edelman, David ;
Davidson, Mayer B. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2447-2453
[24]   Elevated A1C in Adults Without a History of Diabetes in the US [J].
Selvin, Elizabeth ;
Zhu, Hong ;
Brancati, Frederick L. .
DIABETES CARE, 2009, 32 (05) :828-833
[25]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[26]   Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults [J].
Sung, K. C. ;
Rhee, E. J. .
DIABETIC MEDICINE, 2007, 24 (08) :848-854
[27]   Longitudinal association of glucose metabolism with retinopathy - Results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study [J].
Tapp, Robyn J. ;
Tikellis, Gabriella ;
Wong, Tien Y. ;
Harper, C. Alex ;
Zimmet, Paul Z. ;
Shaw, Jonathan E. .
DIABETES CARE, 2008, 31 (07) :1349-1354
[28]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853
[29]  
van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245
[30]   THE RELATIONSHIP BETWEEN GLYCOSYLATED HEMOGLOBIN LEVELS AND VARIOUS DEGREES OF GLUCOSE-INTOLERANCE [J].
VERRILLO, A ;
DETERESA, A ;
GOLIA, R ;
NUNZIATA, V .
DIABETOLOGIA, 1983, 24 (05) :391-393